ALCIDION GROUP LIMITED (ALC)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

ALC - ALCIDION GROUP LIMITED

FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Debt/EBITDA: -1.4
Index:

Alcidion Group provides clinical information technology to support clinicians in decision making, ensuring quality of care for patients. The company operates in Australia and the UK. It listed on the ASX in 2011.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.044

11 Apr
2024

-0.002

OPEN

$0.05

-4.35%

HIGH

$0.05

798,378

LOW

$0.04

TARGET
$0.05 13.6% upside
OTHER COMPANIES IN THE SAME SECTOR
ACL . AHX . BMT . CAJ . DOC . EBO . HLS . M7T . MDR . MPL . MVF . NHF . PSQ . RHC . SHL .
FNARENA'S MARKET CONSENSUS FORECASTS
ALC: 1
Title FY22
Actual
FY23
Actual
FY24
Forecast
FY25
Forecast
EPS (cps) xxx N/A - 0.6 xxx
DPS (cps) xxx N/A 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx N/A N/A xxx
PE Ratio xxx N/A N/A xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

0.00

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201820192020202120222023
EPS Basic xxxxxxxxxxxxxxx-0.3
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx40.4 M
Book Value Per Share xxxxxxxxxxxxxxx7.1
Net Operating Cash Flow xxxxxxxxxxxxxxx0.2 M
Net Profit Margin xxxxxxxxxxxxxxx-8.95 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201820192020202120222023
Return on Capital Employed xxxxxxxxxxxxxxx-3.93 %
Return on Invested Capital xxxxxxxxxxxxxxx-3.86 %
Return on Assets xxxxxxxxxxxxxxx-2.90 %
Return on Equity xxxxxxxxxxxxxxx-3.93 %
Return on Total Capital xxxxxxxxxxxxxxx-5.01 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-0.3 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201820192020202120222023
Short-Term Debt xxxxxxxxxxxxxxx1 M
Long Term Debt xxxxxxxxxxxxxxx1 M
Total Debt xxxxxxxxxxxxxxx2 M
Goodwill - Gross xxxxxxxxxxxxxxx68 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx15 M
Price To Book Value xxxxxxxxxxxxxxx1.34

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201820192020202120222023
Capex xxxxxxxxxxxxxxx0.5 M
Capex % of Sales xxxxxxxxxxxxxxx1.12 %
Cost of Goods Sold xxxxxxxxxxxxxxx39 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx6 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx-

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

1
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Bell Potter

05/03/2024

3

Hold

$0.05

13.64%

Despite an 8% rise in A&NZ revenue in the 1H on the previous corresponding period, total revenue for Alcidion Group fell -15% short of Bell Potter's forecast due to an -8% decline in UK revenues. 

The UK disappointment was due to ongoing delays for National Health Service electronic patient record (EPR) tenders, explains the broker. Due to these delays, the company is reducing headcount to realise an annual reduction in operating expenses of -$6.4m.

Should 2H revenue equal that of the 1H, as management expects, total FY24 revenue will be down -6% on FY23, notes the analyst.

"It will not be possible to deliver positive EBITDA in FY24" as previously guided, stated the company.

The target falls to 5c from 8c and the Hold rating is unchanged.

FORECAST
Bell Potter forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -0.60 cents.
Bell Potter forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -0.20 cents.

ALC STOCK CHART